ACSS2 and Alzheimer disease: We found that GTA supplementation (an FDA-approved food additive) increased the total acetyl-CoA and histone acetylation levels in the hippocampus of the late-stage AD mice (Fig. 6A-B), which was obviously prevented in the Acss2-knockdown mice (Fig. 7F-G).